|
|
 |
|
|||||
 |
 |
|
    |
|
|
|
|
From Targeted Science to Better Healthcare™
Clinical Data is a global biotechnology company developing a rich pipeline of targeted therapeutics. Our late-stage compounds includes two unique products, vilazodone™, a first-in-class drug candidate for the treatment of depression, and Stedivaze™, a potential best-in-class cardiac stress agent. By virtue of each compound’s targeted effect they offer potential advantages over currently available treatments, and may provide tangible benefits for patients, healthcare professionals and payers. The Company’s PGxHealth Division is leveraging its expertise in biomarker discovery and commercialization to guide the development of our drug pipeline. PGxHealth also leads the commercial and laboratory efforts supporting our FAMILION® family of genetic tests for inherited heart diseases. Recent Releases
Feb 2, 2010
Jan 6, 2010 Events
Feb 8, 2010
Jan 14, 2010 |
Investors:
Shareholder Tools
|
||
|
|
| Clinical Data © 1999-2010. All Rights Reserved. Terms of Use. |
